Same patients, different risks: a head-to-head of ESC and EACS CVD guidelines in PLWH
2025 Falasca, K; Chiappini, F; Di Gasbarro, A; Gallina, S; Vecchiet, J; Ucciferri, C
Real-life switch to long-acting cabotegravir/rilpivirine ensures adequate drug levels without short-term impact on viral reservoir or inflammation: the Long-Icona study
2025 Gagliardini, R; Tempestilli, M; El Khalili, O; Bono, V; De Benedettis, S; Germani, A; Carrara, S; Mazzotta, V; Tincati, C; Carrozzo, G; Schiaroli, E; Tavelli, A; Antinori, A; Ceccherini-Silberstein, F; Marchetti, G; Monforte, Ad
Weight gain and metabolic complications in a large prospective cohort of overweight and obese people with HIV
2025 Taramasso, L; Ricci, E; Squillace, N; Costacurta, L; Orofino, G; Pellicanò, Gf; De Socio, G; Menzaghi, B; Ferrara, S; Maggi, P; Pontali, E; Piconi, S; Sarchi, E; Madeddu, G; Carleo, Ma; Martini, S; Salomoni, E; Bini, T; Cenderello, G; Celesia, Bm; Gulminetti, R; Bargiacchi, O; Cascio, A; Falasca, K; Lagi, F; Bonfanti, P; Di Biagio, A
Safety and durability of treatment with bictegravir/emtricitabine/tenofovir alafenamide in a real-life cohort
2025 Squillace, N; Ricci, E; Maggi, P; Taramasso, L; Menzaghi, B; Sarchi, E; De Socio, G; Piconi, S; Pellicanò, Gf; Bini, T; Madeddu, G; Martini, S; Pontali, E; Cenderello, G; Bandera, A; Celesia, Bm; Orofino, G; Ferrara, S; Carleo, Ma; Cascio, A; Di Biagio, A; Bonfanti, P
High burden of hepatic steatosis, fibrosis, and cardiometabolic risk in HIV-monoinfected adults on antiretroviral therapy: STEAT-HIV results
2026 Quartini, G; Di Giuli, C; Saraca, Lm; Capogrossi, L; Svizzeretto, E; Genga, G; Proietti, G; Cordoni, M; Gentili, F; Fiore, P; De Socio, Gvl; Ucciferri, C
Durability of lenacapavir in viremic HTE PWH: real-world data from the PRESTIGIO registry
2025 Clemente, T.; Torkjazi, G.; Capra, N.; Gagliardini, R.; Cattelan, A. M.; Lolatto, R.; Fronti, E.; Fiscon, M.; De Socio, G.; Orofino, G.; Santoro, M. M.; Spagnuolo, V.; Study Group, Prestigio
Multiple melanoma, ichthyosis, and juvenile cataracts in a patient with a germline mutation in CDKN2A: pure coincidence or related association?
2025 De Giorgi, V; Fazzari, F; Cecchi, G; Perillo, G; Zuccaro, B; Covarelli, P
Extension of the clinical and genetic spectrum in SPG4 discloses a new form of Alzheimer’s disease.
2025 Panza, E; Meyyazhagan, A; Picchi, E; Ribas, G; Faber, I; Miyamoto, R; Basavaraju, P; Kuchi Bhotla, H; Stasi, M; Patti, F; Santorelli, Fm; França Jr., Mc; Pedroso, Jl; Barsottini, Ogp; Teive, Hag; St George-Hyslop, Ph; Kawarai, T; Orlacchio, Antonio
The identification of two novel intronic variants of the SPG4/SPAST gene with pathogenic effect reveals a novel genotype-phenotype correlation
2025 Orlacchio, Antonio; Evangelisti, C; Stasi, M; Meyyazhagan, A; Basavaraju, P; Ribas, G; Fava, N; Ramadan, S; Miele, M; Miyamoto, R; Pedroso, J; Barsottini, O; Teive, H; Panza, E
Reduced percentage of postovulatory natural killer cells associated with impaired cytokines network in the secretory endometrium of infertile PCOS women
2010 Matteo, Maria; Greco, P; Santopietro, X; Noviello, A; De Rosario, M; Cho, Y; Falagario, T; Totaro, R; Massenzio, F; Liso, Arcangelo; Serviddio, Gaetano
High anti PLAC 1 antibody levels in idiopathic infertile patients with repetaed unexplained implantation failure
2011 Matteo, Maria; Stracci, F; Massenzio, Francesca; De Rosario, F; Mastricci, L; Santopietro, X; Chunxin, Lin; Greco, P; Liso, Arcangelo
SARS_CoV2 Critically ill patients, :Focus on Nutrition
2021 Scarcella, M; R., Commissari; S., Cappanera; E., Sensi; M., Scimmi; B., Tiri; Robertis, E. D.
Vitamin D and depressive disorder in a HIV positive patients: Dual therapy (DTG based) versus standard triple therapy
2023 Moffa, L; Ucciferri, C; Falasca, K; Vecchiet, J
Pidotimod: A therapeutic option in COVID19 outpatients
2023 Di Gasbarro, A; Di Rosa, Z; Taraschi, G; Vecchiet, J; Falasca, K; Ucciferri, C
Inflammation in HIV positive subjects on antiretroviral therapy: Two-drug DTG based vs triple standard antiretroviral therapy
2023 Ucciferri, C; Frisenda, C; Falasca, K; Vecchiet, J
Deflazacort as a new option for diabetic patients with COVID-19
2023 Di Gasbarro, A; Taraschi, G; Falasca, K; Vecchiet, J; Ucciferri, C
“Vitamin D and cardiovascular risk in HIV + subjets”
2011 Ucciferri, C; Falasca, K; Mancino, P; Vignale, F; Di Biase, J; Pizzigallo, E; Vecchiet, J.
“Improves metabolic assessment in HIV positive patients in combination anti-retroviral therapy (cART) switching to darunavir/ritonavir (DRV/r) from lopinavir/ritonavir (LPV/r) or fosamprenavir/ritonavir (FPV/r)”
2011 Ucciferri, C; Vignale, F; Falasca, K; Mancino, P; Pizzigallo, E; Vecchiet, J.
Relations between cardiovascular risk estimates and subclinical atherosclerosis in naı¨ve HIV patients: results from the HERMES study
2009 De Socio, G; C., Martinelli2; E., Ricci3; G., Orofino4; L., Valsecchi3; P., Vitiello3; L., Martinelli1; T., Quirino5; P., Maggi6; P., Bonfanti3
ADVERSE EFFECTS OF HIV INFECTION ON DAY-NIGHT BLOOD PRESSURE VARIABILITY
2010 G., Schillaci1; G., Pucci1; C., Martinelli2; T., Quirino3; P., Bonfanti4; De Socio, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Same patients, different risks: a head-to-head of ESC and EACS CVD guidelines in PLWH | 2025 | Falasca, K; Chiappini, F; Di Gasbarro, A; Gallina, S; Vecchiet, J; Ucciferri, C | |
| Real-life switch to long-acting cabotegravir/rilpivirine ensures adequate drug levels without short-term impact on viral reservoir or inflammation: the Long-Icona study | 2025 | Gagliardini, R; Tempestilli, M; El Khalili, O; Bono, V; De Benedettis, S; Germani, A; Carrara, S; Mazzotta, V; Tincati, C; Carrozzo, G; Schiaroli, E; Tavelli, A; Antinori, A; Ceccherini-Silberstein, F; Marchetti, G; Monforte, Ad | |
| Weight gain and metabolic complications in a large prospective cohort of overweight and obese people with HIV | 2025 | Taramasso, L; Ricci, E; Squillace, N; Costacurta, L; Orofino, G; Pellicanò, Gf; De Socio, G; Menzaghi, B; Ferrara, S; Maggi, P; Pontali, E; Piconi, S; Sarchi, E; Madeddu, G; Carleo, Ma; Martini, S; Salomoni, E; Bini, T; Cenderello, G; Celesia, Bm; Gulminetti, R; Bargiacchi, O; Cascio, A; Falasca, K; Lagi, F; Bonfanti, P; Di Biagio, A | |
| Safety and durability of treatment with bictegravir/emtricitabine/tenofovir alafenamide in a real-life cohort | 2025 | Squillace, N; Ricci, E; Maggi, P; Taramasso, L; Menzaghi, B; Sarchi, E; De Socio, G; Piconi, S; Pellicanò, Gf; Bini, T; Madeddu, G; Martini, S; Pontali, E; Cenderello, G; Bandera, A; Celesia, Bm; Orofino, G; Ferrara, S; Carleo, Ma; Cascio, A; Di Biagio, A; Bonfanti, P | |
| High burden of hepatic steatosis, fibrosis, and cardiometabolic risk in HIV-monoinfected adults on antiretroviral therapy: STEAT-HIV results | 2026 | Quartini, G; Di Giuli, C; Saraca, Lm; Capogrossi, L; Svizzeretto, E; Genga, G; Proietti, G; Cordoni, M; Gentili, F; Fiore, P; De Socio, Gvl; Ucciferri, C | |
| Durability of lenacapavir in viremic HTE PWH: real-world data from the PRESTIGIO registry | 2025 | Clemente, T.; Torkjazi, G.; Capra, N.; Gagliardini, R.; Cattelan, A. M.; Lolatto, R.; Fronti, E.; Fiscon, M.; De Socio, G.; Orofino, G.; Santoro, M. M.; Spagnuolo, V.; Study Group, Prestigio | |
| Multiple melanoma, ichthyosis, and juvenile cataracts in a patient with a germline mutation in CDKN2A: pure coincidence or related association? | 2025 | De Giorgi, V; Fazzari, F; Cecchi, G; Perillo, G; Zuccaro, B; Covarelli, P | |
| Extension of the clinical and genetic spectrum in SPG4 discloses a new form of Alzheimer’s disease. | 2025 | Panza, E; Meyyazhagan, A; Picchi, E; Ribas, G; Faber, I; Miyamoto, R; Basavaraju, P; Kuchi Bhotla, H; Stasi, M; Patti, F; Santorelli, Fm; França Jr., Mc; Pedroso, Jl; Barsottini, Ogp; Teive, Hag; St George-Hyslop, Ph; Kawarai, T; Orlacchio, Antonio | |
| The identification of two novel intronic variants of the SPG4/SPAST gene with pathogenic effect reveals a novel genotype-phenotype correlation | 2025 | Orlacchio, Antonio; Evangelisti, C; Stasi, M; Meyyazhagan, A; Basavaraju, P; Ribas, G; Fava, N; Ramadan, S; Miele, M; Miyamoto, R; Pedroso, J; Barsottini, O; Teive, H; Panza, E | |
| Reduced percentage of postovulatory natural killer cells associated with impaired cytokines network in the secretory endometrium of infertile PCOS women | 2010 | Matteo, Maria; Greco, P; Santopietro, X; Noviello, A; De Rosario, M; Cho, Y; Falagario, T; Totaro, R; Massenzio, F; Liso, Arcangelo; Serviddio, Gaetano | |
| High anti PLAC 1 antibody levels in idiopathic infertile patients with repetaed unexplained implantation failure | 2011 | Matteo, Maria; Stracci, F; Massenzio, Francesca; De Rosario, F; Mastricci, L; Santopietro, X; Chunxin, Lin; Greco, P; Liso, Arcangelo | |
| SARS_CoV2 Critically ill patients, :Focus on Nutrition | 2021 | Scarcella, M; R., Commissari; S., Cappanera; E., Sensi; M., Scimmi; B., Tiri; Robertis, E. D. | |
| Vitamin D and depressive disorder in a HIV positive patients: Dual therapy (DTG based) versus standard triple therapy | 2023 | Moffa, L; Ucciferri, C; Falasca, K; Vecchiet, J | |
| Pidotimod: A therapeutic option in COVID19 outpatients | 2023 | Di Gasbarro, A; Di Rosa, Z; Taraschi, G; Vecchiet, J; Falasca, K; Ucciferri, C | |
| Inflammation in HIV positive subjects on antiretroviral therapy: Two-drug DTG based vs triple standard antiretroviral therapy | 2023 | Ucciferri, C; Frisenda, C; Falasca, K; Vecchiet, J | |
| Deflazacort as a new option for diabetic patients with COVID-19 | 2023 | Di Gasbarro, A; Taraschi, G; Falasca, K; Vecchiet, J; Ucciferri, C | |
| “Vitamin D and cardiovascular risk in HIV + subjets” | 2011 | Ucciferri, C; Falasca, K; Mancino, P; Vignale, F; Di Biase, J; Pizzigallo, E; Vecchiet, J. | |
| “Improves metabolic assessment in HIV positive patients in combination anti-retroviral therapy (cART) switching to darunavir/ritonavir (DRV/r) from lopinavir/ritonavir (LPV/r) or fosamprenavir/ritonavir (FPV/r)” | 2011 | Ucciferri, C; Vignale, F; Falasca, K; Mancino, P; Pizzigallo, E; Vecchiet, J. | |
| Relations between cardiovascular risk estimates and subclinical atherosclerosis in naı¨ve HIV patients: results from the HERMES study | 2009 | De Socio, G; C., Martinelli2; E., Ricci3; G., Orofino4; L., Valsecchi3; P., Vitiello3; L., Martinelli1; T., Quirino5; P., Maggi6; P., Bonfanti3 | |
| ADVERSE EFFECTS OF HIV INFECTION ON DAY-NIGHT BLOOD PRESSURE VARIABILITY | 2010 | G., Schillaci1; G., Pucci1; C., Martinelli2; T., Quirino3; P., Bonfanti4; De Socio, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2369
Data di pubblicazione
- 2020 - 2026106
- 2010 - 20191001
- 2000 - 2009960
- 1990 - 1999256
- 1980 - 198942
- 1973 - 19794
Editore
- Springer Verlag Germany:Tiergarte...11
- Edizioni Minerva Medica:Corso Bra...5
- Editore attuale:BLACKWELL PUBLISH...2
- -Milano: Istituto nazionale per t...1
- Attuale:OXFORD UNIV PRESS, GREAT ...1
- BMJ Publishing Group, London1
- Elsevier Science Limited:Oxford F...1
- EWRR1
- Macmillan Magazines Limited:Porte...1
- Mary Ann Liebert Incorporated:2 M...1
Rivista
- BLOOD115
- HAEMATOLOGICA81
- NEUROUROLOGY AND URODYNAMICS80
- EUROPEAN UROLOGY. SUPPLEMENTS75
- GASTROENTEROLOGY75
- THE JOURNAL OF UROLOGY66
- URODINAMICA64
- JOURNAL OF PLANT PATHOLOGY45
- ANNALS OF THE RHEUMATIC DISEASES43
- BLOOD TRANSFUSION40
Keyword
- female urology32
- urinary incontinence30
- urodynamics28
- surgery27
- pelvic organ prolapse18
- stress urinary incontinence15
- voiding dysfunction13
- botulinum a toxin12
- resiniferatoxin12
- prostate cancer11
Lingua
- eng1613
- ita153
- enm1
- fre1
Accesso al fulltext
- no fulltext2369